# PD-1 Antibody Improve Mixed Chimerism

> **NCT04944511** · NA · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- PD-1 Antibody
- Mixed Chimerism

## Interventions

- **DRUG:** Toripalimab Injection

## Key facts

- **NCT ID:** NCT04944511
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-01
- **Final completion:** 2023-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04944511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04944511, "PD-1 Antibody Improve Mixed Chimerism". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04944511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*